![]() |
市場調查報告書
商品編碼
1541598
2024-2032 年按產品類型(植入式除顫器、體外去顫器)、最終用戶(醫院和診所、院前護理機構、心臟中心、家庭護理機構等)和地區分類的除顫器市場報告Defibrillators Market Report by Product Type (Implantable Defibrillators, External Defibrillators), End-User (Hospitals and Clinics, Prehospital Care Settings, Cardiac Centers, Homecare Settings, and Others), and Region 2024-2032 |
2023年全球除顫器市場規模達54IMARC Group美元。冠狀動脈疾病和心律不整等心臟病發病率的增加、公共接入點數量的增加以及救護車服務數量的增加是推動市場的一些主要因素。
除顫器是一種醫療設備,旨在透過向心臟提供電擊來恢復正常心跳。它們的設計易於使用,以確保未經醫療培訓的人也可以在緊急情況下操作它們。它們在涉及心臟驟停的緊急情況下至關重要,心臟驟停是一種心臟突然停止有效跳動的情況。它們提供電擊,可以使心臟恢復正常節律,這可能會挽救一個人的生命。它們通常用於醫院、救護車以及機場和購物中心等公共場所。
冠狀動脈疾病和心律不整等心臟病的發生率不斷增加,推動了世界各地對除顫器的需求。此外,購物中心、公園和交通樞紐等公共場所數量的增加有利於市場的成長。此外,越來越多的救護車服務在車輛上配備了除顫器,以加強運輸過程中的緊急醫療護理,這對市場產生了積極影響。除此之外,體育和健身產業的擴張正在增加除顫器在健身房、體育設施和娛樂場所的採用。此外,肥胖症的盛行率飆升與心臟問題的較高風險有關,也推動了市場的成長。
提高人們對心臟健康的認知
由於大眾對心臟健康的認知不斷增強,對去顫器的需求不斷增加。個人和組織越來越認知到與心臟驟停 (SCA) 相關的風險,這種情況可能發生在任何地方的任何人身上。這種意識的提高促使我們採取積極主動的準備措施。學校、辦公室、公共場所甚至家庭都認知到備有除顫器的重要性。在關鍵時刻拯救生命的潛力推動了需求。此外,教育活動和培訓舉措揭開了除顫器使用的神秘面紗,使其更易於使用和方便用戶使用。
人口老化和慢性病增加
全球人口老化是刺激除顫器需求的另一個重要因素。隨著年齡的成長,心臟相關問題的風險也會增加。此外,高血壓、糖尿病等慢性病盛行率也呈現上升趨勢。這些情況可能導致心臟問題,這使得除顫器成為緊急應變的重要醫療設備。醫療機構、老年生活社區和家庭護理提供者都在投資除顫器,以確保在發生心臟緊急情況時及時介入。這種人口結構的變化預計將維持並進一步刺激對去顫器的需求。
不斷成長的立法和監管任務
監管要求和立法在推動除顫器需求方面發揮了關鍵作用。許多國家和地區已實施法律,要求特定地點(例如機場、體育場和公共建築)配備自動體外心臟去顫器 (AED)。這個法律框架迫切需要組織遵守這些要求,從而導致除顫器採購的增加。此外,建築業和製造業等職業健康和安全標準較高的行業正在投資除顫器,以確保合規性並增強工作場所安全。立法和安全法規的整合使除顫器成為緊急應變基礎設施不可或缺的組成部分。
The global defibrillators market size reached US$ 5.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.0 Billion by 2032, exhibiting a growth rate (CAGR) of 5.6% during 2024-2032. The increasing incidence of heart diseases, such as coronary artery disease and arrhythmias, rising number of public access locations, and the growing number of ambulance services are some of the major factors propelling the market.
Defibrillators are medical devices designed to restore a normal heartbeat by delivering an electrical shock to the heart. They are designed to be user friendly to ensure that people without medical training can also operate them in emergency situations. They are crucial in emergency situations involving cardiac arrest, which is a condition wherein the heart suddenly stops beating effectively. They provide an electrical shock that can jolt the heart back into a normal rhythm, which potentially saves the life of an individual. They are commonly used in hospitals, ambulances, and public places like airports and shopping malls.
Increasing incidence of heart diseases, such as coronary artery disease and arrhythmias, is driving the demand for defibrillators around the world. Moreover, the rising number of public access locations, including malls, parks, and transportation hubs, is favoring the growth of the market. In addition, the growing number of ambulance services that are equipped with defibrillators in vehicles to enhance emergency medical care during transit is influencing the market positively. Apart from this, the expansion of the sports and fitness industry is increasing the adoption of defibrillators in gyms, sports facilities, and recreational areas. Furthermore, the surging prevalence of obesity, which is correlated with a higher risk of cardiac issues, is bolstering the market growth.
Increasing awareness about cardiac health
The demand for defibrillators is on a rise due to the increasing awareness about cardiac health among the masses. Individuals and organizations are becoming more cognizant of the risks associated with sudden cardiac arrest (SCA), which can strike anyone, anywhere. This heightened awareness has led to a proactive approach in preparedness. Schools, offices, public spaces, and even households are recognizing the importance of having defibrillators readily available. The potential to save lives in critical moments has driven the demand. Moreover, educational campaigns and training initiatives have demystified the use of defibrillators, making them more accessible and user-friendly.
Rise in aging population and chronic diseases
The aging population worldwide is another significant factor catalyzing the demand for defibrillators. As people age, the risk of cardiac-related issues increases. Moreover, the surging prevalence of chronic diseases, such as hypertension and diabetes has also risen. These conditions can lead to heart problems, which makes defibrillators a crucial medical device for emergency response. Healthcare facilities, senior living communities, and home care providers are all investing in defibrillators to ensure timely intervention in case of cardiac emergencies. This demographic shift is expected to sustain and further catalyzing the demand for defibrillators.
Growing legislation and regulatory mandates
Regulatory mandates and legislation have played a pivotal role in driving the demand for defibrillators. Many countries and regions have implemented laws requiring specific locations, such as airports, sports stadiums, and public buildings, to have automated external defibrillators (AEDs) readily available. This legal framework has created a compelling need for organizations to comply with these requirements, thus leading to increased procurement of defibrillators. Additionally, industries with high occupational health and safety standards like construction and manufacturing are investing in defibrillators to ensure compliance and enhance workplace safety. The convergence of legislation and safety regulations has made defibrillators an indispensable component of emergency response infrastructure.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product type, and end-user.
Implantable Defibrillators
Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
Cardiac Resynchronization Therapy Defibrillator (CRT-D)
External Defibrillators
Manual External Defibrillator
Automated External Defibrillator (AEDs)
Wearable Cardioverter Defibrillator (WCDs)
Automated external defibrillator (AEDs) dominate the market
The report has provided a detailed breakup and analysis of the market based on the product type. This includes implantable defibrillators [transvenous implantable cardioverter defibrillator (T-ICDs), subcutaneous implantable cardioverter defibrillator (S-ICDs), and cardiac resynchronization therapy defibrillator (CRT-D)] and external defibrillators [manual external defibrillator, automated external defibrillator (AEDs), and wearable cardioverter defibrillator (WCDs)]. According to the report, automated external defibrillator (AEDs) represented the largest segment. AEDs are designed to be used by the public and are commonly found in public places like schools, airports, and shopping centers. They come with pre-set energy levels and automated voice instructions, making them user-friendly. They can automatically analyze the heart rhythm of the patients and advise whether a shock is needed, which ensures that the device is not misused.
T-ICDs are inserted into the body via a vein, typically in the upper chest area. They are connected to the heart through leads placed inside the veins. The device continually monitors the rhythm of the heart and automatically administers an electrical shock when it detects dangerous arrhythmias. T-ICDs are commonly used in patients who have had previous episodes of sudden cardiac arrest or are at high risk for it.
Hospitals and Clinics
Prehospital Care Settings
Cardiac Centers
Homecare Settings
Others
Hospitals and clinics hold the largest share in the market
A detailed breakup and analysis of the market based on the end-user has also been provided in the report. This includes hospitals and clinics, prehospital care settings, cardiac centers, homecare settings, and others. According to the report, hospitals and clinics accounted for the largest market share. In hospitals and clinics, defibrillators are a standard part of the medical equipment available for emergency care. Usually, these healthcare settings use manual external defibrillators, which allow medical professionals more control over the treatment process. These devices are often integrated into advanced life-support systems and used in conjunction with other monitoring equipment to provide comprehensive care. The staff in these settings are typically well-trained in the use of these sophisticated devices, which ensures that patients who experience cardiac emergencies have immediate access to potentially life-saving interventions. Hospitals and clinics are controlled environments with skilled personnel and they are often best suited for managing complex or high-risk cardiac events.
Prehospital care settings refer to emergency medical services that are administered before a patient arrives at a hospital. This can include care given by paramedics in ambulances or first responders at the scene of a medical emergency. In these settings, AEDs or portable manual external defibrillators are commonly used. AEDs are especially useful in this context because they can be operated by a broader range of medical personnel and even by bystanders under guidance, allowing for more immediate intervention. Prehospital care providers often receive specialized training in cardiac life support, which includes the effective use of defibrillators.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance, accounting for the largest defibrillators market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
The surging prevalence of cardiovascular-related health issues represents one of the primary factors driving the demand for defibrillators in the North America region. Moreover, the rising public awareness about the risks of sudden cardiac arrest is favoring the growth of the market in the region. Besides this, a well-established healthcare facilities are influencing the market positively in the region.
Asia Pacific is estimated to witness stable growth, owing to ongoing research and development (R&D) projects, government initiatives, integration of advanced technologies, etc.
The leading companies are developing advanced defibrillators that are equipped with real time monitoring and feedback mechanisms to provide instant analysis of a heart rhythm of a patient and offer guidance to the operator, which improves the chances of successful defibrillation. Moreover, key players are introducing defibrillators integrated with touch screen technology, voice-guided prompts, and visual aids to reduce the time it takes to administer life-saving treatment. They are also adopting the usage of wireless connectivity that allows for remote monitoring and data analysis and enables healthcare providers to keep track of device performance and patient data seamlessly, which can be invaluable for post-care assessment and ongoing treatment planning.
Asahi Kasei Zoll Medical Corporation
Biotronik
Boston Scientific Corporation
Koninklijke Philips N.V.
LivaNova PLC
Medtronic Inc.
Nihon Kohden Corporation
Schiller AG
Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
Stryker Corporation
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
In 2020, Koninklijke Philips N.V. announced that its Emergency Care and Resuscitation (ECR) business recommenced the US manufacturing and shipping of external defibrillators.
In 2022, Medtronic Inc. declared that its investigational EV ICD(TM) System - a first-of-its-kind defibrillator with the lead placed under the breastbone, outside of the heart and veins - achieved a defibrillation success rate of 98.7% and met its safety endpoints in a global clinical trial.
In July 2021, Asahi Kasei Zoll Medical Corporation stated that it has received FDA 510(k) clearance to release the TBI Dashboard(TM) feature on its Propaq(R) M monitor and Propaq MD monitor/defibrillator.